RTW Investments’s GeneDx Holdings WGS Stock Holding History

RTW Investments’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,121	Closed	-$1.78M	–	121
2021 Q4	$1.78M	Hold	12,121	–	–	0.03%	112
2021 Q3	$2.94M	Buy	+12,121	New	+$4.16M	0.04%	104

Other funds holding WGS

Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

RTW Investments's WGS Position: Q1 2022 in Review

RTW Investments sold out of GeneDx Holdings (WGS) in Q1 2022, closing a stake of 12,121 shares — an estimated $1.78M sold.

RTW Investments first reported a position in WGS in Q3 2021 and held it in 2 quarters. The position peaked at $2.94M in Q3 2021. 108 funds tracked by Wall St. Rank hold WGS as of Q1 2022.

RTW Investments reported no remaining GeneDx Holdings position as of Q1 2022 after selling out during the quarter.
RTW Investments sold 12,121 GeneDx Holdings shares in Q1 2022, an estimated $1.78M.
RTW Investments first reported a position in GeneDx Holdings in Q3 2021 and held it in 2 quarters.
RTW Investments's GeneDx Holdings position peaked at $2.94M in Q3 2021.
108 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2022.

Based on RTW Investments's 13F filing for Q1 2022, filed 16 May 2022.